Cargando…

Quantification of LVEF≤35% misclassification by 2D-echocardiography as compared to cardiac magnetic resonance in coronary artery disease: implications for AICD therapy

Detalles Bibliográficos
Autores principales: Parrington, Diane J, Saremi, Aramesh, Girotra, Sudhakar V, Dev, Sandesh, Oh, Charles, Scott, Cynthia L, Migrino, Raymond Q
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3304749/
http://dx.doi.org/10.1186/1532-429X-14-S1-P212
_version_ 1782226932593590272
author Parrington, Diane J
Saremi, Aramesh
Girotra, Sudhakar V
Dev, Sandesh
Oh, Charles
Scott, Cynthia L
Migrino, Raymond Q
author_facet Parrington, Diane J
Saremi, Aramesh
Girotra, Sudhakar V
Dev, Sandesh
Oh, Charles
Scott, Cynthia L
Migrino, Raymond Q
author_sort Parrington, Diane J
collection PubMed
description
format Online
Article
Text
id pubmed-3304749
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-33047492012-03-16 Quantification of LVEF≤35% misclassification by 2D-echocardiography as compared to cardiac magnetic resonance in coronary artery disease: implications for AICD therapy Parrington, Diane J Saremi, Aramesh Girotra, Sudhakar V Dev, Sandesh Oh, Charles Scott, Cynthia L Migrino, Raymond Q J Cardiovasc Magn Reson Poster Presentation BioMed Central 2012-02-01 /pmc/articles/PMC3304749/ http://dx.doi.org/10.1186/1532-429X-14-S1-P212 Text en Copyright ©2012 Parrington et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Poster Presentation
Parrington, Diane J
Saremi, Aramesh
Girotra, Sudhakar V
Dev, Sandesh
Oh, Charles
Scott, Cynthia L
Migrino, Raymond Q
Quantification of LVEF≤35% misclassification by 2D-echocardiography as compared to cardiac magnetic resonance in coronary artery disease: implications for AICD therapy
title Quantification of LVEF≤35% misclassification by 2D-echocardiography as compared to cardiac magnetic resonance in coronary artery disease: implications for AICD therapy
title_full Quantification of LVEF≤35% misclassification by 2D-echocardiography as compared to cardiac magnetic resonance in coronary artery disease: implications for AICD therapy
title_fullStr Quantification of LVEF≤35% misclassification by 2D-echocardiography as compared to cardiac magnetic resonance in coronary artery disease: implications for AICD therapy
title_full_unstemmed Quantification of LVEF≤35% misclassification by 2D-echocardiography as compared to cardiac magnetic resonance in coronary artery disease: implications for AICD therapy
title_short Quantification of LVEF≤35% misclassification by 2D-echocardiography as compared to cardiac magnetic resonance in coronary artery disease: implications for AICD therapy
title_sort quantification of lvef≤35% misclassification by 2d-echocardiography as compared to cardiac magnetic resonance in coronary artery disease: implications for aicd therapy
topic Poster Presentation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3304749/
http://dx.doi.org/10.1186/1532-429X-14-S1-P212
work_keys_str_mv AT parringtondianej quantificationoflvef35misclassificationby2dechocardiographyascomparedtocardiacmagneticresonanceincoronaryarterydiseaseimplicationsforaicdtherapy
AT saremiaramesh quantificationoflvef35misclassificationby2dechocardiographyascomparedtocardiacmagneticresonanceincoronaryarterydiseaseimplicationsforaicdtherapy
AT girotrasudhakarv quantificationoflvef35misclassificationby2dechocardiographyascomparedtocardiacmagneticresonanceincoronaryarterydiseaseimplicationsforaicdtherapy
AT devsandesh quantificationoflvef35misclassificationby2dechocardiographyascomparedtocardiacmagneticresonanceincoronaryarterydiseaseimplicationsforaicdtherapy
AT ohcharles quantificationoflvef35misclassificationby2dechocardiographyascomparedtocardiacmagneticresonanceincoronaryarterydiseaseimplicationsforaicdtherapy
AT scottcynthial quantificationoflvef35misclassificationby2dechocardiographyascomparedtocardiacmagneticresonanceincoronaryarterydiseaseimplicationsforaicdtherapy
AT migrinoraymondq quantificationoflvef35misclassificationby2dechocardiographyascomparedtocardiacmagneticresonanceincoronaryarterydiseaseimplicationsforaicdtherapy